Yazar "Kalincik, T." için listeleme

Toplam kayıt 18, listelenen: 1-18

10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort

Jokubaitis, V. G.; Spelman, T.; Kalincik, T.; Travaglini, D.; Paolicelli, D.; Duquette, P.; Verheul, F. (Sage Publications Ltd, 2015)

…
Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis

Kalincik, T.; Jokubaitis, V.; Spelman, T.; Horakova, D.; Havrdova, E.; Trojano, M.; Barnett, M. (Sage Publications Ltd, 2017)

…
Comparative analysis of MS outcomes in dimethyl fumarate-treated patients relative to propensity matched fingolimod, interferon, glatiramer acetate, or teriflunomide

Spelman, T.; Kalincik, T.; Trojano, M.; Grand'Maison, F.; Izquierdo, G.; Havrdova, E.; Butzkueven, H. (Sage Publications Ltd, 2016)

…
Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry.

Spelman, T.; Harvrdova, E. K.; Horakova, D.; Izquierdo, G.; Kalincik, T.; Lugaresi, A.; McCombe, P. (Sage Publications Ltd, 2018)

…
Comparative efficacy of first-line natalizumab versus IFNb or glatiramer acetate in relapsing MS

Spelman, T.; Kalincik, T.; Jokubaitis, V.; Zhang, A.; Pellegrini, F.; Wiendl, H.; Lechner-Scott, J. (Sage Publications Ltd, 2015)

…
Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis

Kalincik, T.; Horakova, D.; Spelman, T.; Jokubaitis, V.; Trojano, M.; Lugaresi, A.; Bergamaschi, R. (Sage Publications Ltd, 2014)

…
Comparison of 5-year treatment outcomes between alemtuzumab versus natalizumab, fingolimod and interferon beta-1a

Kalincik, T.; Brown, J. W.; Robertson, N.; Willis, M.; Scolding, N.; Pearson, O.; Lechner-Scott, J. (Sage Publications Ltd, 2016)

…
Comparison of the effectiveness of rituximab versus alemtuzumab and natalizumab in active relapsing-remitting MS

Kalincik, T.; Malpas, C. B.; Sharmin, S.; Roos, I.; Patti, F.; Butzkueven, H.; Sa, M. J. (Sage Publications Ltd, 2019)

…
Determinants of disability accumulation in secondary-progressive multiple sclerosis.

Lizak, N.; Malpas, C.; Sharmin, S.; Havrdova, E.; Horakova, D.; Izquierdo, G.; Kalincik, T. (Sage Publications Ltd, 2018)

…
Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years

Kalincik, T.; Spelman, T.; Jokubaitis, V.; Horakova, D.; Havrdova, E.; Trojano, M.; Pucci, E. (Sage Publications Ltd, 2017)

…
Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study

Kalincik, T.; Spelman, T.; Jokubaitis, V.; Horakova, D.; Havrdova, E.; Izquierdo, G.; McCombe, P. (Sage Publications Ltd, 2017)

…
Efficacy and Treatment Persistence of First-line Natalizumab vs. Interferon beta or Glatiramer Acetate in relapsing MS.

Butzkueven, H.; Spelman, T.; Kalincik, T.; Jokubaitis, V.; Zhang, A.; Pellegrini, F.; La Spitaleri, D. (Sage Publications Ltd, 2016)

…
Evaluation of common criteria of progression of disability in a large observational cohort

Kalincik, T.; Jokubaitis, V.; Spelman, T.; Horakova, D.; Havrdova, E.; Trojano, M.; Terzi, M. (Sage Publications Ltd, 2014)

…
Individual response to disease modifying therapies: a global observational cohort study

Kalincik, T.; Sobisek, L.; Jokubaitis, V.; Spelman, T.; Horakova, D.; Havrdova, E.; Granella, F. (Sage Publications Ltd, 2016)

…
Modifiers of the effectiveness of MS immunotherapies

Kalincik, T.; Malpas, C.; Sharmin, S.; Horakova, D.; Havrdova, E. K.; Trojano, M.; Van Pesch, V. (Sage Publications Ltd, 2019)

…
MS cohorts and treatment utilization in academic centres in the Middle East

Moradi, N.; Sharmin, S.; Malpas, C.; Ozakbas, S.; Shaygannejad, V.; Alroughani, R.; Kalincik, T. (Sage Publications Ltd, 2019)

…
Personalizing treatment effect based on patient's baseline profile: a statistical modelling approach applied to randomized clinical trial and observational study data

Bovis, F.; Kalincik, T.; Lublin, F.; Cutter, G.; Malpas, C.; Horakova, D.; Hupperts, R. (Sage Publications Ltd, 2019)

…
Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis

Jokubaitis, V. G.; Havrdova, E.; Horakova, D.; Izquierdo, G.; Kalincik, T.; van der Walt, A.; Pucci, E. (Sage Publications Ltd, 2017)

…